389650 fundamentals
An in-depth look to NEXTBIOMEDICAL CO., LTD. operating, investing, and financing activities
389650 free cash flow for Q4 24 is -1.16 B KRW. For 2024, 389650 free cash flow was -1.64 B KRW and operating cash flow was -1.2 B KRW.
Q3 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: KRW
Q3 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
TTM